The function of the DataBase Shared Resource (DBSR) is to develop, integrate, and maintain a centralized, cost-effective, and well-characterized research database encompassing all the Herbert Irving Comprehensive Cancer Center (HICCC) tumor registries. Directed by Jeanine Genkinger, PhD and Katherine Crew, MD, MS, the DBSR has, over the past five years, developed a standardized protocol with universal consent of individuals with cancer or at risk for cancer to promote novel and innovative cancer research within the HICCC, as well as the larger Columbia University Irving Medical Center (CUIMC) community. The DBSR provides oversight and infrastructure for the development and maintenance of a cancer-related research database across multiple cancer subspecialties including: (1) integration of all prior adult solid tumor registries into one standardized protocol; (2) development of a retrospective cohort of patients through linkage of data from electronic health records (EHRs) across multiple platforms and data warehouses (i.e., New York-Presbyterian Hospital [NYPH] Tumor Registry) with existing residual tissue samples; and (3) development and maintenance of a prospective cohort implemented through consenting, collecting biospecimens (e.g., blood, saliva) and epidemiologic data (e.g., lifestyle factors), and linking to data from the EHR/NYPH Tumor Registry and residual tissue samples. DBSR also coordinates research database-related services with other Shared Resources. In addition, DBSR provides support to the research community by: (1) incorporating recruitment to ancillary studies in the cancer clinics via recruitment staff, (2) reviewing requests to access the cancer-related research database via a dedicated Scientific Review Committee and tracking utilization of requests (i.e., manuscripts published, funding awarded), and (3) disseminating information about the cancer-related research database to the research and lay community to promote novel and innovative cancer research. Over the current project period (2014-2019), DBSR integrated 24 clinical registries into one overarching research database. Due to highly qualified and bilingual recruiters, DBSR has met its accrual targets and enrolled over 4,700 individuals, from whom DBSR has collected over 2,400 biospecimens, and over 2,600 questionnaires. To foster highly innovative research, the DBSR has approved and fulfilled over 120 data and biospecimen requests and supported over 10 ancillary studies through efficient enrollment and data extraction. Through this, the DBSR has supported several federally funded grants. Over the current project period, the capabilities of the DBSR have been utilized by 35 HICCC members and supported key data and insights for 31 HICCC member peer-reviewed publications, including five papers with impact factor >10 and manuscripts in reference cancer journals (e.g., Cancer Epidemiology, Biomarkers & Prevention, Clinical Cancer Research, Cancer Prevention Research). Currently DBSR support research in three NCI-funded research project grants.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-45
Application #
10022768
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-07-04
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Arnes, Luis; Liu, Zhaoqi; Wang, Jiguang et al. (2018) Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Gut :
Petersen-Jones, Simon M; Occelli, Laurence M; Winkler, Paige A et al. (2018) Patients and animal models of CNG?1-deficient retinitis pigmentosa support gene augmentation approach. J Clin Invest 128:190-206
Sones, Jennifer L; Merriam, Audrey A; Seffens, Angelina et al. (2018) Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia. FASEB J 32:2574-2586
Park, Karen Sophia; Xu, Christine L; Cui, Xuan et al. (2018) Reprogramming the metabolome rescues retinal degeneration. Cell Mol Life Sci 75:1559-1566
Mumau, Melanie D; Vanderbeck, Ashley N; Lynch, Elizabeth D et al. (2018) Identification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1. J Immunol 200:1078-1087
Savage, Thomas M; Shonts, Brittany A; Obradovic, Aleksandar et al. (2018) Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. JCI Insight 3:
Caviglia, Jorge Matias; Yan, Jun; Jang, Myoung-Kuk et al. (2018) MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology 67:2414-2429
Jauregui, Ruben; Park, Karen Sophia; Tsang, Stephen H (2018) Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa. Ophthalmic Genet 39:544-549
Wu, Wen-Hsuan; Tsai, Yi-Ting; Justus, Sally et al. (2018) CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology. Methods Mol Biol 1715:191-205
Yen, Bonnie; Fortson, Katherine T; Rothman, Nyanza J et al. (2018) Clonal Bifurcation of Foxp3 Expression Visualized in Thymocytes and T Cells. Immunohorizons 2:119-128

Showing the most recent 10 out of 331 publications